Previous 10 | Next 10 |
home / stock / stz / stz articles
On Thursday, Constellation Brands Inc (NYSE: STZ) touted the strong performance of its beer portfolio as the Corona beer maker raised its annu...
Constellation Brands Inc (NYSE: STZ) on Thursday reported upbeat earnings for its second quarter. The company reported second-quarter FY24 net sale...
The CNN Money Fear and Greed index showed some growth in the fear level, remaining in the "Extreme Fear" zone on Thursday. U.S. stocks cl...
Risk aversion returned on Thursday as stocks retraced their gains from Wednesday. Traders are now closely monitoring the eagerly anticipated non-fa...
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.45% to 32...
CNBC Disney Slashes Children's Ticket Prices Amid Attendance Slump The Walt Disney Company (NYSE: DIS) has unveiled a new series of disco...
Constellation Brands Inc (NYSE: STZ), an international producer and marketer of beer, wine, and spirits, reported second-quarter FY2...
Wednesday’s recovery could prove short-lived, going by the trading in stock futures, which points to a slightly lower opening on Thursday. Bo...
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street ...
News, Short Squeeze, Breakout and More Instantly...
Constellation Brands Inc. Company Name:
STZ Stock Symbol:
NYSE Market:
Constellation Brands Inc. Website:
2024-07-09 07:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-05 08:15:04 ET UBS analyst issues BUY recommendation for STZ on July 5, 2024 07:02AM ET. The previous analyst recommendation was Buy. STZ was trading at $249.21 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recom...